ARCHIVES

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Burton’s Clinic Reported Operating In Spite of Closure

December 13, 1985

AACR honors Five With Awards Next Month

April 2, 1993

U.S. Breast Cancer Death Rate Declines.

September 28, 2007

Centers Urged To Apply For Comprehensive Status By June 1

February 16, 1990

‘Dear Dr. Bick’: Letters Reflect Turmoil Over Conflict Of Interest

January 26, 1990

List of core grants renewed in FY 2003, full list of center grants.

January 16, 2004